Cargando…
Pyrvinium Targets the Unfolded Protein Response to Hypoglycemia and Its Anti-Tumor Activity Is Enhanced by Combination Therapy
We identified pyrvinium pamoate, an old anthelminthic medicine, which preferentially inhibits anchorage-independent growth of cancer cells over anchorage-dependent growth (∼10 fold). It was also reported by others to have anti-tumor activity in vivo and selective toxicity against cancer cells under...
Autores principales: | Yu, De-Hua, Macdonald, James, Liu, Guohong, Lee, Amy S., Ly, Mimi, Davis, Timothy, Ke, Ning, Zhou, Demin, Wong-Staal, Flossie, Li, Qi-Xiang |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2597738/ https://www.ncbi.nlm.nih.gov/pubmed/19079611 http://dx.doi.org/10.1371/journal.pone.0003951 |
Ejemplares similares
-
Pyrvinium Pamoate: Past, Present, and Future as an Anti-Cancer Drug
por: Schultz, Christopher W., et al.
Publicado: (2022) -
Pyrvinium doubles against WNT-driven cancer
por: Fan, Jiaming, et al.
Publicado: (2022) -
Targeting HCV Entry For Development of Therapeutics
por: Wong-Staal, Flossie, et al.
Publicado: (2010) -
Pyrvinium Pamoate and Structural Analogs Are Early Macrofilaricide Leads
por: Gunderson, Emma L., et al.
Publicado: (2022) -
Reprofiling a classical anthelmintic, pyrvinium pamoate, as an anti-cancer drug targeting mitochondrial respiration
por: Ishii, Isao, et al.
Publicado: (2012)